The Effect of Dual Trigger (GnRH Agonist + hCG) for Final Maturation in Oocyte Donors With History of a Previous Cycle With Suboptimal Response to GnRH Agonist Only Trigger
The goal of this clinical trial is to compare GnRH-agonist trigger with dual GnRH-agonist and HCG trigger in oocyte donors.
The main questions it aims to answer are:
Maturation rate (Metaphase II/ Total number of COCs collected)
Fertilization rate
Embryo quality day 3
Fragmentation rate embryo day 3
Blastulation rate (Day5/6/7)
Quality of blastocyst (Gardner criteria) Participants will undergo controlled ovarian stimulation with a GnRH antagonist protocol Researchers will compare the effects of final maturation with GnRH-agonist trigger to a dual trigger (hCG and GnRH-a)
100 Clinical Results associated with Embryolab
0 Patents (Medical) associated with Embryolab
100 Deals associated with Embryolab
100 Translational Medicine associated with Embryolab